REPL::Tender/ Acquisition/ Takeover/ Purchase Offer::Mandatory

Issuer & Securities

Issuer/ Manager
TIANJIN ZHONG XIN PHARM GROUP
Security
TIANJIN ZHONG XIN PHARM GROUP - CNE100000924 - T14

Announcement Details

Announcement Title
Mandatory Tender/ Acquisition/ Takeover/ Purchase Offer
Date &Time of Broadcast
26-Mar-2021 22:45:44
Status
Replacement
Corporate Action Reference
SG210119TENDZQKM
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board

Event Narrative

Narrative Type
Narrative Text
OfferorTianjin Pharmaceutical (Singapore) International Investment Pte. Ltd.
Additional TextPlease refer to the attached Offeree Response Announcement.

The attached Offeree Response Announcement is the same announcement as released by the Company on 20 December 2020, and the reason for the re-upload using the Tender/ Acquisition/ Takeover/ Purchase Offer::Mandatory template is pursuant to CDP s request.
Additional TextRESPONSE TO FORMAL OFFER ANNOUNCEMENT AND APPOINTMENT OF INDEPENDENT FINANCIAL ADVISERS AND ELECTRONIC DESPATCH OF OFFER DOCUMENT

Disbursement Details

Existing Security Details
Disbursement Type
Cash
Cash Payment Details
Offer Price
USD 0.894

Attachments

20201220 TJZX - Offeree Response Announcement.pdf
20210326 TJZX - Response to Formal Offer and Appt of IFAs Annc.pdf
Total size =909K

Related Announcements

Related Announcements

30/04/2021 14:56:49
09/04/2021 18:04:37
19/01/2021 19:01:19